Editas Medicine Inc. (EDIT)
NASDAQ: EDIT
· Real-Time Price · USD
2.15
0.18 (9.14%)
At close: Jun 16, 2025, 3:59 PM
2.15
-0.23%
After-hours: Jun 16, 2025, 07:50 PM EDT
9.14% (1D)
| Bid | 2.05 |
| Market Cap | 180.4M |
| Revenue (ttm) | 31.18M |
| Net Income (ttm) | -251.23M |
| EPS (ttm) | -3.04 |
| PE Ratio (ttm) | -0.71 |
| Forward PE | -1.92 |
| Analyst | Hold |
| Ask | 2.17 |
| Volume | 2,625,615 |
| Avg. Volume (20D) | 1,974,825 |
| Open | 2.00 |
| Previous Close | 1.97 |
| Day's Range | 1.93 - 2.20 |
| 52-Week Range | 0.91 - 6.05 |
| Beta | 2.10 |
About EDIT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EDIT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EDIT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
-23.81%
Editas Medicine shares are trading lower after Sti...
Unlock content with
Pro Subscription
6 months ago
-5.03%
Editas Medicine shares are trading higher after the company announced plans to transition to an in vivo focus and initiated a reduction in headcount, aiming to eliminate approximately 65% of its workforce over the next six months.
